Cognitive function of patients with brain tumor in pre- and postoperative stage

Abstract Background Nobody knows whether cognitive dysfunction affects survival. Furthermore, it is unknown whether the dysfunction is caused by the tumor itself or by its treatment. Methods Patients with 20 gliomas (LGG, 7; MG, 13 [AG, 4; GM, 9]) in the right brain (nondominant) and 11 gliomas (LGG...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgical neurology 2008, Vol.69 (1), p.51-61
Hauptverfasser: Yoshii, Yoshihiko, MD, Tominaga, Daisuke, PhD, Sugimoto, Kouichi, MD, Tsuchida, Yukihiro, MD, Hyodo, Akio, MD, Yonaha, Hirokatsu, MD, Kushi, Sukemitsu, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 61
container_issue 1
container_start_page 51
container_title Surgical neurology
container_volume 69
creator Yoshii, Yoshihiko, MD
Tominaga, Daisuke, PhD
Sugimoto, Kouichi, MD
Tsuchida, Yukihiro, MD
Hyodo, Akio, MD
Yonaha, Hirokatsu, MD
Kushi, Sukemitsu, MD
description Abstract Background Nobody knows whether cognitive dysfunction affects survival. Furthermore, it is unknown whether the dysfunction is caused by the tumor itself or by its treatment. Methods Patients with 20 gliomas (LGG, 7; MG, 13 [AG, 4; GM, 9]) in the right brain (nondominant) and 11 gliomas (LGG, 1; MG, 10 [AG, 6; GM, 4]) in the left brain (dominant) were studied. Thirty-four patients with meningioma were also studied. Cognitive function was evaluated by the 3MS examination, and propriety of radical resection of tumor was reviewed. Results Cognitive function pre-Op and post-Op was normal in patients with LGG and MGs in the right brain but decreased before an Op in all patients with MG in the left brain, and they did not normalize after Op. In patients with MG in left brain, the test of temporal and spatial orientation, first recall, similarities, 4-legged animals, mental reversal, and writing decreased after Op. Cognitive hypofunction before or after Op did not correlate with tumor malignancy and degree of tumor resection. Conclusion Firstly, radical Op should aim at improvement of cognitive function for patients with glioma in the right brain, and for patients with glioma in the left brain, QOL should be thought about without expecting improvement of cognitive function. Secondly, improvement of cognitive function cannot be anticipated in patients with meningioma in the left brain. Aged patients older than 75 years require carefulness in Op. Then, damage of the cingulated gyrus and corpus callosum should be avoided in the left brain. This study emphasizes that clinicians should be careful in the evaluation of cognitive function in glioma and meningioma treatment.
doi_str_mv 10.1016/j.surneu.2007.07.064
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70097013</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090301907009196</els_id><sourcerecordid>70097013</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-3aef56cd0fa21c8166b193a8a1a05a94af2d6dcf08441b28b7442355db397e1b3</originalsourceid><addsrcrecordid>eNqFkU-LFDEQxYMo7rj6DURy8tZjVSed7lwEGfwHC3tQzyGdrl4z9nTaJL2y3960MyB4EQoqh_deeL9i7CXCHgHVm-M-rXGmdV8DtPttlHzEdti1uhJC6MdsB6ChEoD6ij1L6QgAQjf6KbvCDhqpUO3Y7SHczT77e-LjOrvsw8zDyBebPc058V8-f-d9tH7meT2FyMtjiVRxOw98CSmHhaL940_Z3tFz9mS0U6IXl33Nvn14__Xwqbq5_fj58O6mchKbXAlLY6PcAKOt0XWoVI9a2M6ihcZqacd6UIMboZMS-7rrWylr0TRDL3RL2Itr9vqcu8Twc6WUzcknR9NkZwprMm3p3gKKIpRnoYshpUijWaI_2fhgEMwG0hzNGaTZQJptlCy2V5f8tT_R8Nd0IVcEb88CKi3vPUWTXEHmaPCRXDZD8P_74d8AN_nZOzv9oAdKx1AshaBBk2oD5st2zO2WsFVDrcRvpjqb2Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70097013</pqid></control><display><type>article</type><title>Cognitive function of patients with brain tumor in pre- and postoperative stage</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Yoshii, Yoshihiko, MD ; Tominaga, Daisuke, PhD ; Sugimoto, Kouichi, MD ; Tsuchida, Yukihiro, MD ; Hyodo, Akio, MD ; Yonaha, Hirokatsu, MD ; Kushi, Sukemitsu, MD</creator><creatorcontrib>Yoshii, Yoshihiko, MD ; Tominaga, Daisuke, PhD ; Sugimoto, Kouichi, MD ; Tsuchida, Yukihiro, MD ; Hyodo, Akio, MD ; Yonaha, Hirokatsu, MD ; Kushi, Sukemitsu, MD</creatorcontrib><description>Abstract Background Nobody knows whether cognitive dysfunction affects survival. Furthermore, it is unknown whether the dysfunction is caused by the tumor itself or by its treatment. Methods Patients with 20 gliomas (LGG, 7; MG, 13 [AG, 4; GM, 9]) in the right brain (nondominant) and 11 gliomas (LGG, 1; MG, 10 [AG, 6; GM, 4]) in the left brain (dominant) were studied. Thirty-four patients with meningioma were also studied. Cognitive function was evaluated by the 3MS examination, and propriety of radical resection of tumor was reviewed. Results Cognitive function pre-Op and post-Op was normal in patients with LGG and MGs in the right brain but decreased before an Op in all patients with MG in the left brain, and they did not normalize after Op. In patients with MG in left brain, the test of temporal and spatial orientation, first recall, similarities, 4-legged animals, mental reversal, and writing decreased after Op. Cognitive hypofunction before or after Op did not correlate with tumor malignancy and degree of tumor resection. Conclusion Firstly, radical Op should aim at improvement of cognitive function for patients with glioma in the right brain, and for patients with glioma in the left brain, QOL should be thought about without expecting improvement of cognitive function. Secondly, improvement of cognitive function cannot be anticipated in patients with meningioma in the left brain. Aged patients older than 75 years require carefulness in Op. Then, damage of the cingulated gyrus and corpus callosum should be avoided in the left brain. This study emphasizes that clinicians should be careful in the evaluation of cognitive function in glioma and meningioma treatment.</description><identifier>ISSN: 0090-3019</identifier><identifier>EISSN: 1879-3339</identifier><identifier>DOI: 10.1016/j.surneu.2007.07.064</identifier><identifier>PMID: 18054616</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>3MS examination ; Aged ; Aged, 80 and over ; Brain Neoplasms - pathology ; Brain Neoplasms - psychology ; Brain Neoplasms - surgery ; Cognition - physiology ; Cognitive function ; Dominant/Nondominant brain ; Female ; Follow-Up Studies ; Glioma ; Glioma - pathology ; Glioma - psychology ; Glioma - surgery ; Humans ; Male ; Meningeal Neoplasms - pathology ; Meningeal Neoplasms - psychology ; Meningeal Neoplasms - surgery ; Meningioma ; Meningioma - pathology ; Meningioma - psychology ; Meningioma - surgery ; Middle Aged ; Neurology ; Neuropsychological Tests ; Prospective Studies ; Recovery of Function - physiology ; Surgery ; Treatment ; Treatment Outcome</subject><ispartof>Surgical neurology, 2008, Vol.69 (1), p.51-61</ispartof><rights>Elsevier Inc.</rights><rights>2008 Elsevier Inc.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-3aef56cd0fa21c8166b193a8a1a05a94af2d6dcf08441b28b7442355db397e1b3</citedby><cites>FETCH-LOGICAL-c415t-3aef56cd0fa21c8166b193a8a1a05a94af2d6dcf08441b28b7442355db397e1b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18054616$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yoshii, Yoshihiko, MD</creatorcontrib><creatorcontrib>Tominaga, Daisuke, PhD</creatorcontrib><creatorcontrib>Sugimoto, Kouichi, MD</creatorcontrib><creatorcontrib>Tsuchida, Yukihiro, MD</creatorcontrib><creatorcontrib>Hyodo, Akio, MD</creatorcontrib><creatorcontrib>Yonaha, Hirokatsu, MD</creatorcontrib><creatorcontrib>Kushi, Sukemitsu, MD</creatorcontrib><title>Cognitive function of patients with brain tumor in pre- and postoperative stage</title><title>Surgical neurology</title><addtitle>Surg Neurol</addtitle><description>Abstract Background Nobody knows whether cognitive dysfunction affects survival. Furthermore, it is unknown whether the dysfunction is caused by the tumor itself or by its treatment. Methods Patients with 20 gliomas (LGG, 7; MG, 13 [AG, 4; GM, 9]) in the right brain (nondominant) and 11 gliomas (LGG, 1; MG, 10 [AG, 6; GM, 4]) in the left brain (dominant) were studied. Thirty-four patients with meningioma were also studied. Cognitive function was evaluated by the 3MS examination, and propriety of radical resection of tumor was reviewed. Results Cognitive function pre-Op and post-Op was normal in patients with LGG and MGs in the right brain but decreased before an Op in all patients with MG in the left brain, and they did not normalize after Op. In patients with MG in left brain, the test of temporal and spatial orientation, first recall, similarities, 4-legged animals, mental reversal, and writing decreased after Op. Cognitive hypofunction before or after Op did not correlate with tumor malignancy and degree of tumor resection. Conclusion Firstly, radical Op should aim at improvement of cognitive function for patients with glioma in the right brain, and for patients with glioma in the left brain, QOL should be thought about without expecting improvement of cognitive function. Secondly, improvement of cognitive function cannot be anticipated in patients with meningioma in the left brain. Aged patients older than 75 years require carefulness in Op. Then, damage of the cingulated gyrus and corpus callosum should be avoided in the left brain. This study emphasizes that clinicians should be careful in the evaluation of cognitive function in glioma and meningioma treatment.</description><subject>3MS examination</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Brain Neoplasms - pathology</subject><subject>Brain Neoplasms - psychology</subject><subject>Brain Neoplasms - surgery</subject><subject>Cognition - physiology</subject><subject>Cognitive function</subject><subject>Dominant/Nondominant brain</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Glioma</subject><subject>Glioma - pathology</subject><subject>Glioma - psychology</subject><subject>Glioma - surgery</subject><subject>Humans</subject><subject>Male</subject><subject>Meningeal Neoplasms - pathology</subject><subject>Meningeal Neoplasms - psychology</subject><subject>Meningeal Neoplasms - surgery</subject><subject>Meningioma</subject><subject>Meningioma - pathology</subject><subject>Meningioma - psychology</subject><subject>Meningioma - surgery</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Neuropsychological Tests</subject><subject>Prospective Studies</subject><subject>Recovery of Function - physiology</subject><subject>Surgery</subject><subject>Treatment</subject><subject>Treatment Outcome</subject><issn>0090-3019</issn><issn>1879-3339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU-LFDEQxYMo7rj6DURy8tZjVSed7lwEGfwHC3tQzyGdrl4z9nTaJL2y3960MyB4EQoqh_deeL9i7CXCHgHVm-M-rXGmdV8DtPttlHzEdti1uhJC6MdsB6ChEoD6ij1L6QgAQjf6KbvCDhqpUO3Y7SHczT77e-LjOrvsw8zDyBebPc058V8-f-d9tH7meT2FyMtjiVRxOw98CSmHhaL940_Z3tFz9mS0U6IXl33Nvn14__Xwqbq5_fj58O6mchKbXAlLY6PcAKOt0XWoVI9a2M6ihcZqacd6UIMboZMS-7rrWylr0TRDL3RL2Itr9vqcu8Twc6WUzcknR9NkZwprMm3p3gKKIpRnoYshpUijWaI_2fhgEMwG0hzNGaTZQJptlCy2V5f8tT_R8Nd0IVcEb88CKi3vPUWTXEHmaPCRXDZD8P_74d8AN_nZOzv9oAdKx1AshaBBk2oD5st2zO2WsFVDrcRvpjqb2Q</recordid><startdate>2008</startdate><enddate>2008</enddate><creator>Yoshii, Yoshihiko, MD</creator><creator>Tominaga, Daisuke, PhD</creator><creator>Sugimoto, Kouichi, MD</creator><creator>Tsuchida, Yukihiro, MD</creator><creator>Hyodo, Akio, MD</creator><creator>Yonaha, Hirokatsu, MD</creator><creator>Kushi, Sukemitsu, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2008</creationdate><title>Cognitive function of patients with brain tumor in pre- and postoperative stage</title><author>Yoshii, Yoshihiko, MD ; Tominaga, Daisuke, PhD ; Sugimoto, Kouichi, MD ; Tsuchida, Yukihiro, MD ; Hyodo, Akio, MD ; Yonaha, Hirokatsu, MD ; Kushi, Sukemitsu, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-3aef56cd0fa21c8166b193a8a1a05a94af2d6dcf08441b28b7442355db397e1b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>3MS examination</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Brain Neoplasms - pathology</topic><topic>Brain Neoplasms - psychology</topic><topic>Brain Neoplasms - surgery</topic><topic>Cognition - physiology</topic><topic>Cognitive function</topic><topic>Dominant/Nondominant brain</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Glioma</topic><topic>Glioma - pathology</topic><topic>Glioma - psychology</topic><topic>Glioma - surgery</topic><topic>Humans</topic><topic>Male</topic><topic>Meningeal Neoplasms - pathology</topic><topic>Meningeal Neoplasms - psychology</topic><topic>Meningeal Neoplasms - surgery</topic><topic>Meningioma</topic><topic>Meningioma - pathology</topic><topic>Meningioma - psychology</topic><topic>Meningioma - surgery</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Neuropsychological Tests</topic><topic>Prospective Studies</topic><topic>Recovery of Function - physiology</topic><topic>Surgery</topic><topic>Treatment</topic><topic>Treatment Outcome</topic><toplevel>online_resources</toplevel><creatorcontrib>Yoshii, Yoshihiko, MD</creatorcontrib><creatorcontrib>Tominaga, Daisuke, PhD</creatorcontrib><creatorcontrib>Sugimoto, Kouichi, MD</creatorcontrib><creatorcontrib>Tsuchida, Yukihiro, MD</creatorcontrib><creatorcontrib>Hyodo, Akio, MD</creatorcontrib><creatorcontrib>Yonaha, Hirokatsu, MD</creatorcontrib><creatorcontrib>Kushi, Sukemitsu, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Surgical neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yoshii, Yoshihiko, MD</au><au>Tominaga, Daisuke, PhD</au><au>Sugimoto, Kouichi, MD</au><au>Tsuchida, Yukihiro, MD</au><au>Hyodo, Akio, MD</au><au>Yonaha, Hirokatsu, MD</au><au>Kushi, Sukemitsu, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cognitive function of patients with brain tumor in pre- and postoperative stage</atitle><jtitle>Surgical neurology</jtitle><addtitle>Surg Neurol</addtitle><date>2008</date><risdate>2008</risdate><volume>69</volume><issue>1</issue><spage>51</spage><epage>61</epage><pages>51-61</pages><issn>0090-3019</issn><eissn>1879-3339</eissn><abstract>Abstract Background Nobody knows whether cognitive dysfunction affects survival. Furthermore, it is unknown whether the dysfunction is caused by the tumor itself or by its treatment. Methods Patients with 20 gliomas (LGG, 7; MG, 13 [AG, 4; GM, 9]) in the right brain (nondominant) and 11 gliomas (LGG, 1; MG, 10 [AG, 6; GM, 4]) in the left brain (dominant) were studied. Thirty-four patients with meningioma were also studied. Cognitive function was evaluated by the 3MS examination, and propriety of radical resection of tumor was reviewed. Results Cognitive function pre-Op and post-Op was normal in patients with LGG and MGs in the right brain but decreased before an Op in all patients with MG in the left brain, and they did not normalize after Op. In patients with MG in left brain, the test of temporal and spatial orientation, first recall, similarities, 4-legged animals, mental reversal, and writing decreased after Op. Cognitive hypofunction before or after Op did not correlate with tumor malignancy and degree of tumor resection. Conclusion Firstly, radical Op should aim at improvement of cognitive function for patients with glioma in the right brain, and for patients with glioma in the left brain, QOL should be thought about without expecting improvement of cognitive function. Secondly, improvement of cognitive function cannot be anticipated in patients with meningioma in the left brain. Aged patients older than 75 years require carefulness in Op. Then, damage of the cingulated gyrus and corpus callosum should be avoided in the left brain. This study emphasizes that clinicians should be careful in the evaluation of cognitive function in glioma and meningioma treatment.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>18054616</pmid><doi>10.1016/j.surneu.2007.07.064</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-3019
ispartof Surgical neurology, 2008, Vol.69 (1), p.51-61
issn 0090-3019
1879-3339
language eng
recordid cdi_proquest_miscellaneous_70097013
source MEDLINE; Alma/SFX Local Collection
subjects 3MS examination
Aged
Aged, 80 and over
Brain Neoplasms - pathology
Brain Neoplasms - psychology
Brain Neoplasms - surgery
Cognition - physiology
Cognitive function
Dominant/Nondominant brain
Female
Follow-Up Studies
Glioma
Glioma - pathology
Glioma - psychology
Glioma - surgery
Humans
Male
Meningeal Neoplasms - pathology
Meningeal Neoplasms - psychology
Meningeal Neoplasms - surgery
Meningioma
Meningioma - pathology
Meningioma - psychology
Meningioma - surgery
Middle Aged
Neurology
Neuropsychological Tests
Prospective Studies
Recovery of Function - physiology
Surgery
Treatment
Treatment Outcome
title Cognitive function of patients with brain tumor in pre- and postoperative stage
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T19%3A36%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cognitive%20function%20of%20patients%20with%20brain%20tumor%20in%20pre-%20and%20postoperative%20stage&rft.jtitle=Surgical%20neurology&rft.au=Yoshii,%20Yoshihiko,%20MD&rft.date=2008&rft.volume=69&rft.issue=1&rft.spage=51&rft.epage=61&rft.pages=51-61&rft.issn=0090-3019&rft.eissn=1879-3339&rft_id=info:doi/10.1016/j.surneu.2007.07.064&rft_dat=%3Cproquest_cross%3E70097013%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70097013&rft_id=info:pmid/18054616&rft_els_id=S0090301907009196&rfr_iscdi=true